SCHEMBL9370570

SCHEMBL9370570

NCCCCCSc1nc(-c2ccccc2)c(-c2ccccc2)[nH]1

nearest known ligand 0.86

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
ACAT1 P24752 1/20 0.60
SOAT1 P35610 1/20 0.60

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9664375 0.99 ACAT1 (0.58) ACAT1SOAT1
SCHEMBL9664425 0.94 KDM4E (0.58)
SCHEMBL9213347 0.93 ACAT1 (0.66) ACAT1SOAT1
SCHEMBL9212895 0.93 ACAT1 (0.66) ACAT1SOAT1
SCHEMBL9217701 0.93 ACAT1 (0.66) ACAT1SOAT1
SCHEMBL9210387 0.91 KDM4E (0.64) ACAT1SOAT1
SCHEMBL8476295 0.90 KDM4E (0.62)
SCHEMBL9215059 0.88 KDM4E (0.64)
SCHEMBL9209249 0.86 ACAT1 (0.60) ACAT1SOAT1
SCHEMBL8103993 0.86

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0372445-B1 Imidazoles for the treatment of atherosclerosis DU PONT MERCK PHARMA (US) 1994-03-09 EP disclosed
EP-0372445-A1 Imidazoles for the treatment of atherosclerosis THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) 1990-06-13 EP disclosed